1.
Rhinology
; 60(6): 474-478, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36436220
RESUMO
Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.